SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-24-046896
Filing Date
2024-04-23
Accepted
2024-04-23 16:10:02
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A apvo-2024-defa14a_-_noti.htm DEFA14A 24748
2 GRAPHIC img107515341_0.jpg GRAPHIC 264395
3 GRAPHIC img107515341_1.jpg GRAPHIC 193042
  Complete submission text file 0000950170-24-046896.txt   655424
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37746 | Film No.: 24864902
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)